法国初中学校疫苗接种项目的实施:是否高效?
本研究分析法国诺曼底地区公立初中2019至2023四个学年学校疫苗接种项目的效率。199所学校中18476名11-13岁学生,33.6%的家长接受至少一种疫苗,4464名学生接种。全球疫苗覆盖率从干预前10.7%升至干预后65.7%(p<0.0001),HPV疫苗从14.6%升至79.9%(p<0.0001)。
要点
- 学校接种项目使全球疫苗覆盖率从10.7%升至65.7%(p<0.0001)。
- HPV疫苗覆盖率从14.6%(675/4614)升至79.9%(3685/4614)(p<0.0001)。
- 新冠后时期(2021-2022)与至少一种疫苗未及时接种显著相关(OR:1.4 [1.2-1.9])。
核心结论
- 学校疫苗接种项目有效提高了所有推荐疫苗的覆盖率,不应仅限于HPV等某些疫苗。
研究设计与样本
- 法国诺曼底地区公立初中学校疫苗接种项目,分析2019-2023四个学年,共访问199所学校,涉及18476名11-13岁学生。
- 需家长授权更新以下推荐疫苗:白喉-破伤风-脊髓灰质炎-百日咳;乙型肝炎病毒(HBV);麻疹-腮腺炎-风疹;C群脑膜炎球菌;HPV疫苗。
- 对至少接受一种疫苗的青少年由医生评估并接种。
- 全球疫苗覆盖率定义为完成所有法国强制和推荐疫苗接种。
主要发现
- 199所学校中18476名学生,33.6%(n=6217)的家长接受至少一种疫苗,4464名学生接种(81.9%,4464/5450)。
- 全球疫苗覆盖率干预前为10.7%(n=585),干预后升至65.7%(n=3585)(p<0.0001)。
- C群脑膜炎球菌疫苗覆盖率从干预前64.8%升至干预后87.5%(p<0.0001)。
- HBV疫苗覆盖率从67.6%升至85.6%(p<0.0001)。
- HPV疫苗覆盖率从14.6%(n=675/4614)升至79.9%(n=3685/4614)(p<0.0001)。
临床怎么用
- 原文结论认为学校疫苗接种项目有效提高了所有推荐疫苗的覆盖率,不应仅限于HPV等某些疫苗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Despite various vaccination campaigns coordinated by French authorities, vaccine coverage (VC) in France remains low, especially for human papillomavirus (HPV). The Agence Regionale de Santé established a mandate for vaccination centres in Normandy to develop a school-based vaccination program in public middle schools. The aim of this study was to analyse the efficiency of this program after four academic years (2019-2023). MATERIALS AND METHODS: Authorization from the parents was required to update each of the following recommended vaccinations for their children (aged 11-13-years-old): diphtheria-tetanus-poliomyelitis-pertussis; hepatitis B virus (HBV); measles, mumps and rubella; meningococcal C; and HPV vaccines. Adolescents for whom at least one vaccine has been accepted were seen by the doctor and were vaccinated if needed. Global VC was defined as being vaccinated for all French mandatory and recommended vaccines. The objective of this study was to compare the proportions of global VC pre and post implementation of the school vaccination program during the period study. RESULTS: During the study period, 199 schools were visited. Among the 18,476 students, 33.6 % (n = 6217) of the students' parents accepted at least one vaccine, and 4464 students were vaccinated (81.9 %, 4464/5450). Global preintervention VC was 10.7 % (n = 585), which increased to 65.7 % (n = 3585) after the vaccine intervention (p < 0.0001). VC increased from 64.8 % in preintervention to 87.5 % in postintervention (p < 0.0001) for the meningococcal C vaccine, from 67.6 % to 85.6 % (p < 0.0001) for the HBV vaccine and from 14.6 % (n = 675/4614) to 79.9 % (n = 3685/4614) (p < 0.0001) for the HPV vaccine. In multivariate analysis, the post-COVID-19 period (2021-2022) was significantly associated with not being up to date for at least one vaccine (OR: 1.4 [1.2-1.9]). CONCLUSION: Our study determined that school vaccination program effectively improved VC for all recommended vaccines and should not be restricted to certain vaccines, such as HPV.
引用
- Baldolli A, Fournier A, Roger H, et al. Implementation of school-based vaccination in French middle schools: Efficient or not? Vaccine. 2025. PMID: 40107131. doi:10.1016/j.vaccine.2025.127007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。